Astma II: Pathologie

Allergen exposure activates multiple immune cells including mast cells, macrophages, eosinophils, neutrophils, T and B lymphocytes, and airway epithelial cells. These cells initiate the immune response and trigger chronic inflammation in the airways. This activation is a critical first step in the allergic cascade that leads to asthma symptoms.

When allergens bind to IgE antibodies attached to mast cells, the cells release inflammatory mediators including histamine, cytokines, leukotrienes, and prostaglandins. These mediators recruit additional immune cells and cause bronchoconstriction, vascular congestion, edema, and mucus secretion, resulting in airway obstruction and breathing difficulty.

Asthma involves nerve-related changes in the airways triggered by allergens or irritants. Increased parasympathetic activity leads to muscle contraction, mucus secretion, and airway narrowing. These neural mechanisms work alongside immune responses to produce the characteristic airway obstruction and symptoms of asthma.

Persistent inflammation causes airway remodeling, including fibrosis, smooth muscle hypertrophy, mucus gland hypersecretion, inflammation, and angiogenesis. These permanent structural changes thicken the bronchial wall and reduce airway diameter. Airway remodeling represents a critical long-term consequence of uncontrolled chronic inflammation in asthma.

Allergen exposure in susceptible individuals triggers B lymphocytes to produce allergen-specific IgE antibodies. These antibodies bind to mast cells, sensitizing them for future allergic responses. Upon re-exposure to the same allergen, the IgE-mast cell complex triggers rapid mediator release and airway inflammation.

Environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition. Genetic predisposition affects immune cell activation and IgE production, while environmental triggers like allergens and irritants initiate the inflammatory cascade. Together, these factors determine whether and how severely asthma develops.

Asthma is a chronic obstructive airway disease characterized by reversible airway obstruction and inflammation. While asthma shares airway obstruction features with chronic obstructive pulmonary disease, asthma involves immune-mediated inflammation and hyperresponsiveness. Understanding asthma pathophysiology provides context for comparing chronic obstructive pulmonary disease mechanisms and management approaches.